A phase I/II study of Taxol [paclitaxel], estramustine and quadramet [Samarium-153-SM-lexidronam] in patients with hormone refractory prostate cancer
Latest Information Update: 07 Jul 2006
At a glance
- Drugs Estramustine (Primary) ; Paclitaxel (Primary) ; Samarium 153 lexidronam (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 07 Jul 2006 New trial record.